#672 Oral 6-thioguanine (TG) causes relatively mild and reversible hepatic venoocclusive disease (VOD)

Linda C. Stork(Oregon Health & Science University), P S Gaynon(Children's Hospital of Los Angeles), Margaret Masterson(Children's Oncology Group), Yousif Matloub(Roswell Park Comprehensive Cancer Center), G. Erdmaru(Children's Oncology Group), Robert S. Ettinger(Children's Oncology Group), Bruce Bostrom(Minnesota West Community & Technical College), John F. Kelleher(Children's Oncology Group), M. Blake(Children's Oncology Group), H N Sather, I. Holcenberg(Children's Oncology Group), Philip D Adamson(Christchurch Hospital)
Journal of Pediatric Hematology/Oncology
July 1, 1998
10.1097/00043426-199807000-00109
Cited by 12

Related Papers

Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction
|Circulation|2020|688
Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study
|Journal of the American College of Cardiology|2019|593
A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study
|Blood|2002|496
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
|Blood|2003|361
Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia
|New England Journal of Medicine|1987|334